AnalystsInsight

Andrew Liesch (StoneX): Analyst Track Record and Price‑Target Accuracy

How often Andrew Liesch’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 291 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

Key takeaways

  • Andrew Liesch ranks #922 of 1,121 analysts in Exent’s scoring (4.6★).
  • 62.7% of price targets were reached over 7 years, versus 53.6% for the average analyst.
  • Median time to reach a target: 112 days; 70.6% of calls were up 12 months later.
  • Most‑covered stocks: AX, EQBK, BUSE, EFSC.
  • Free on Exent: Andrew Liesch’s full record, with ratings 3 days after publication.

Andrew Liesch’s track record at a glance

Andrew Liesch of StoneX ranks #922 of the 1,121 analysts Exent scores, with a 4.6★ rating and a focus on financials. Over a 7‑year lookback, 62.7% of Andrew’s price targets were reached, 9.1 points above the 53.6% average across all analysts.

MetricAndrew LieschAll analysts
Price‑target hit rate62.7%53.6%
Median days to hit target112 days91 days
Calls up after 12 months70.6%64.6%
Median 12‑month return of calls+15.1%+13.4%
Hit rate, last 2 years58.9%—
Average worst drop after a call−14.0%—
Ratings in the sample291—
Stocks covered28—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetAndrew Liesch
Under 30 days10.9%
30–90 days29.1%
90–180 days26.9%
Over 180 days33.1%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Andrew Liesch covers most

StockRatings in the sample
AX33
EQBK28
BUSE26
EFSC26
GSBC25
SMBC24
CFFN23
BOH21

In the past year Andrew’s ratings were 33% Buy, 67% Hold and 0% Sell.

Andrew Liesch’s latest ratings

DateStockActionRatingPrice target
Sep 24, 2026HOPEInitiated Coverage: HoldHold$0.00
Sep 24, 2026CATYInitiated Coverage: HoldHold$0.00
Sep 24, 2026FIBKInitiated Coverage: HoldHold$0.00
Jul 8, 2026CPFInitiated Coverage: BuyBuy$44.00
Jul 8, 2026BANRInitiated Coverage: HoldHold$0.00
Jul 8, 2026AXInitiated Coverage: BuyBuy$115.00
Jul 8, 2026FHBInitiated Coverage: HoldHold$0.00
Jul 8, 2026BOHInitiated Coverage: HoldHold$0.00
Jul 8, 2026CFFNInitiated Coverage: BuyBuy$10.00
May 21, 2025BUSEReiterated: BuyBuy$26.00
May 1, 2025AXReiterated: BuyBuy$80.00
Apr 30, 2025PROVReiterated: HoldHold$16.00
  • Sep 24, 2026
    Stock
    HOPE
    Action
    Initiated Coverage: Hold
    Rating
    Hold
    Price target
    $0.00
  • Sep 24, 2026
    Stock
    CATY
    Action
    Initiated Coverage: Hold
    Rating
    Hold
    Price target
    $0.00
  • Sep 24, 2026
    Stock
    FIBK
    Action
    Initiated Coverage: Hold
    Rating
    Hold
    Price target
    $0.00
  • Jul 8, 2026
    Stock
    CPF
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $44.00
  • Jul 8, 2026
    Stock
    BANR
    Action
    Initiated Coverage: Hold
    Rating
    Hold
    Price target
    $0.00
  • Jul 8, 2026
    Stock
    AX
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $115.00
  • Jul 8, 2026
    Stock
    FHB
    Action
    Initiated Coverage: Hold
    Rating
    Hold
    Price target
    $0.00
  • Jul 8, 2026
    Stock
    BOH
    Action
    Initiated Coverage: Hold
    Rating
    Hold
    Price target
    $0.00
  • Jul 8, 2026
    Stock
    CFFN
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $10.00
  • May 21, 2025
    Stock
    BUSE
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $26.00
  • May 1, 2025
    Stock
    AX
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $80.00
  • Apr 30, 2025
    Stock
    PROV
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $16.00

Andrew’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Oct 20, 2026; ranking updated Oct 21, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Andrew Liesch’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Andrew Liesch ranks #922 of 1,121 with a 4.6★ rating. 62.7% of price targets were reached over a 7-year lookback (all analysts: 53.6%), and 70.6% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Andrew Liesch’s success rate is 55.6% by the ranking source and 62.7% by Exent’s price-target hit-rate backtest, with a median of 112 days to reach a target.

Andrew Liesch (StoneX) covers 28 stocks, mostly in financials. The most frequently rated are AX, EQBK, BUSE, EFSC, GSBC.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.